Based on the SMILES representation Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2, the molecule has a drug half life time in humans after IV administration of 4.800 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene